3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
2
Vaping
1
Tobacco Use Disorder
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Endometrial Neoplasms
1
Advanced Solid Tumor
1
Interventions
Radiotherapy
4
osimertinib
3
aflutinib
3
Radiosurgery
3
Pemetrexed
3
Drug Therapy
3
Carboplatin
3
toripalimab
2
pembrolizumab
2
Docetaxel
2
tislelizumab
1
sugemalimab
1
lenvatinib
1
cemiplimab
1
brigatinib
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Surgical Procedures, Operative
1
S 1 (combination)
1
Platinum Compounds
1
Platinum
1
Pharmaceutical Preparations
1
Paclitaxel
1
Neoadjuvant Therapy
1
JDQ443
1
Immune Checkpoint Inhibitors
1
HM781-36B
1
Gemcitabine
1
Diphenhydramine
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
NSCLC
×
BID protein, human
×
1 year
×
Clear all
No trials found.